IDONGESIT ANIEKAN EKPO

Dr. IDONGESIT ANIEKAN EKPO

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IDONGESIT ANIEKAN EKPOIDONGESIT ANIEKAN EKPO
IDONGESIT ANIEKAN EKPO
AOAiremwen Collins Ovenseri
Airemwen Collins Ovenseri
AAAbdulrahman Abdullateef
Abdulrahman Abdullateef
BDBurak Durmaz
Burak Durmaz
Breast cancer remains a major global health issue with a high mortality rate. In breast cancer treatment, chemotherapeutic drugs have a toxic effect on both cancerous and healthy cells which can lead to severe adverse effects and chemoresistance. Chitosan-based nanoparticles (NPs) have been reported to improve cellular drug delivery, thereby remediating the chemoresistance of anticancer drugs. The purpose of this research was to formulate 5-fluorouracil (5-FU) loaded chitosan nanoparticles. 5-FU nanoparticles were synthesized using ionic gelation technique which is based on the ionic interaction of positively charged chitosan and negatively charged tripolyphosphate that serves as a cross linker. The formulated nanoparticles were evaluated using UV spectrophotometer, Fourier-transform infrared spectroscopy, X-ray diffraction, Scanning Electron Microscopy. The cytotoxicity study was done using MTT assays. FTIR analysis revealed complete drug encapsulation of the nanoparticles via intermolecular interactions. The result of the XRD analysis showed that the drug was crystalline in the nanoparticle distribution. The SEM analysis confirmed the spherical morphology and structure. The synthesized nanoparticles had a mean particle size of 218.62 nm, zeta potential values of ≤+32.18 mV, Pdi values ranging from 0.14–0.29 and encapsulation efficiency results of ≤37.54%. The drug release mechanism was via Fickian diffusion. MTT analysis showed a time-dependent cytotoxic effect of 5-FU nanoparticles on breast cancer (MCF-7) cell lines after 72 h. This study confirmed that formulation of 5-FU into nanoparticles is a promising approach for sustained release and site-specific anticancer drug delivery which can potentially minimize the systemic side effects and improve treatment outcomes in cancer patients.

1 January 2022 in International Journal of E-Health and Medical Communications
Verified
Journal Article
Open access
PDF file
CIChiemelie Benneth Iloka
Chiemelie Benneth Iloka
IDONGESIT ANIEKAN EKPOIDONGESIT ANIEKAN EKPO
IDONGESIT ANIEKAN EKPO
Husam RjoubHusam Rjoub
Husam Rjoub
KIKolawole Iyiola
Kolawole Iyiola
JOJamiu Adetola Adetola Odugbesan
Jamiu Adetola Adetola Odugbesan
Research on the attitude of diabetes retinopathy's (DR) patients towards teleophthalmology as a branch of telemedicine has not been examined in developing countries. This article examines the receptiveness attitude of the patients with DR towards the use of teleophthalmology using 400 questionnaires to examine patients in Calabar DR screening center in Cross River State, Nigeria. The hypotheses were tested using multiple indicators multiple causes (MIMIC) as a special case of the structural equation modeling (SEM). The findings in this study indicated high cost and excess time negatively affects patient attitude, information, knowledge, and experience significantly and positively predict patients attitude towards teleophthalmology. Furthermore, the result of the paper shows that convenience and knowledge for 35.7 percent of the receptiveness of patients towards teleophthalmology. This study contributes by identifying that among other factors positive factors to enhance patient's receptive attitude to being diagnosis with diabetes retinopathy through telemedicine.